// Post a message

Replying to:

Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.

In a recent review entitled : Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy, Junjie Wu and David Waxman from the Department of Biology, Division of Cell and Molecular Biology, Boston University, Boston USA review the data about metronomic chemotherapy (MC) and its impact on immunity Indeed, some anti-cancer chemotherapeutic drugs, such as doxorubicin, mitoxantrone, and cyclophosphamide, can kill tumor cells by an immunogenic cell death (...)

pre-moderation

This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?
  • (To create paragraphs, you simply leave blank lines.)

Who are you? (optional)